We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 2,819 results
  1. Incidence of heart valve disease in women treated with the ergot-derived dopamine agonist bromocriptine

    Background

    Ergot-derived dopamine agonists are thought to induce fibrotic changes in cardiac valve leaflets. We sought to determine the incidence of...

    Marianne F. Clausen, Rasmus Rørth, ... Søren Lund Kristensen in BMC Cardiovascular Disorders
    Article Open access 28 December 2021
  2. Unusual acute neonatal mortality and sow agalactia linked with ergot alkaloid contamination of feed

    Background

    An increase in the occurrence of ergot alkaloid contamination has been observed in Europe in recent years. The typical clinical signs of...

    Agnès Waret-Szkuta, Laurent Larraillet, ... Guy-Pierre Martineau in Porcine Health Management
    Article Open access 06 November 2019
  3. Treatment initiation for parkinson’s disease in Australia 2013–2018: a nation-wide study

    Background

    Guidelines highlight the importance of an individualized approach to treatment initiation for Parkinson’s disease. Our aim was to...

    Marjaana Koponen, J. Simon Bell, ... Jenni Ilomäki in BMC Geriatrics
    Article Open access 03 June 2022
  4. Drug Safety in Episodic Migraine Management in Adults Part 1: Acute Treatments

    Purpose of Review

    The aim of this review is to aid in choosing safe options when assessing potential risks of acute migraine treatments based on known...

    Yulia Y. Orlova, Sandhya Mehla, Abigail L. Chua in Current Pain and Headache Reports
    Article 10 May 2022
  5. Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients: an European multicentre survey

    In older patients with Parkinson’s disease (PD), the use of dopamine agonists (DA) has been limited due to uncertainties related to their...

    A. Rizos, A. Sauerbier, ... K. Ray Chaudhuri in Journal of Neural Transmission
    Article Open access 05 May 2020
  6. Sir Henry Dale (1875–1968)

    Stefano Sandrone in Journal of Neurology
    Article Open access 27 March 2024
  7. Role of dopamine agonists in Parkinson's disease therapy

    Dopamine agonists are an important component of Parkinson's therapy. When weighing up the various therapy options, therapy with levodopa has recently...

    D. Woitalla, C. Buhmann, ... D. Weise in Journal of Neural Transmission
    Article 11 May 2023
  8. Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson’s disease

    Continuous drug delivery (CDD) has emerged as a feasible and pragmatic therapeutic option for dopamine replacement therapy in advanced Parkinson’s...

    P. Tall, M. A. Qamar, ... K. Ray Chaudhuri in Journal of Neural Transmission
    Article Open access 01 May 2023
  9. Acute Treatment Patterns, Migraine Burden, and Healthcare Resource Use in People With Migraine: Results From the OVERCOME (EU) Observational Study

    Introduction

    The ObserVational survey of the Epidemiology, tReatment and Care Of MigrainE (OVERCOME) European Union (EU) is part of an overarching...

    Stefan Evers, Grazia Dell’Agnello, ... Julio Pascual in Pain and Therapy
    Article Open access 16 April 2024
  10. Effects of rasagiline combined with levodopa and benserazide hydrochloride on motor function and homocysteine and IGF-1 levels in elderly patients with Parkinson’s disease

    Background

    During the course of their illness, people with Parkinson’s disease may see changes in their insulin-like growth factor (IGF-1) and serum...

    Yifan Yang, Feng Gao, ... Jiaodan Miao in BMC Neurology
    Article Open access 06 October 2023
  11. Medieval surgery (eleventh–thirteenth century): barber surgeons and warfare surgeons in France

    Purpose

    From the eleventh to the thirteenth century, three major events marked surgery in France: the appearance of an epidemic linked to ergotism...

    Philippe Hernigou, Jacques Hernigou, Marius Scarlat in International Orthopaedics
    Article 16 April 2021
  12. How to manage intolerance to dopamine agonist in patients with prolactinoma

    Purpose

    Dopamine agonists (DA) are the gold-standard for prolactinoma and hyperprolactinemia treatment. Intolerance to DA leading to drug drop out...

    Matheo Augusto Morandi Stumpf, Felipe Moura Maia Pinheiro, ... Andrea Glezer in Pituitary
    Article 07 April 2023
  13. Ergotism in feedlot cattle: clinical, hematological, and pathological findings

    Consumption of grains, contaminated with Claviceps purpurea , may cause ergotism in animals. Ruminants are considered relatively sensitive to...

    Peyman Dehghan Rahimabadi, Soroush Yourdkhani, ... Hassan Asgari Rad in Comparative Clinical Pathology
    Article 22 February 2022
  14. Treatment patterns for patients initiating novel acute migraine specific medications (nAMSMs) in the context of monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP) pathway

    Background

    New acute and preventive migraine medications are available, but data on current treatment patterns are limited. This study describes...

    Zifan Zhou, Robert Urman, ... Mark E. Bensink in The Journal of Headache and Pain
    Article Open access 09 November 2023
  15. Addressing the cost of chronic and episodic migraine and its main drivers: a short-term longitudinal analysis from a third-level Italian center

    Background

    Chronic migraine (CM) is one of the most disabling neurological diseases, often associated to medication overuse headache (MOH). These...

    Alberto Raggi, Licia Grazzi, ... Domenico D’Amico in Neurological Sciences
    Article 27 May 2022
  16. Multiple drugs

    Article 27 April 2024
  17. Long-term treatment with lasmiditan in patients with migraine: post hoc analysis of treatment patterns and outcomes from the open-label extension of the CENTURION randomized trial

    Background

    The objective of this analysis was to gain new insights into the patient characteristics and other factors associated with lasmiditan usage...

    Mika Komori, Akichika Ozeki, ... Takao Takeshima in The Journal of Headache and Pain
    Article Open access 25 March 2024
  18. Sex differences in the clinical manifestations related to dependence behaviors in medication-overuse headache

    Objective

    The present study aimed to compare sex differences in the clinical manifestations related to dependence behaviors in medication-overuse...

    Yen-Feng Wang, Yi-Shiang Tzeng, ... Shuu-Jiun Wang in The Journal of Headache and Pain
    Article Open access 01 November 2023
  19. Off-time Treatment Options for Parkinson’s Disease

    Motor fluctuations (MF) are deemed by patients with Parkinson's disease (PD) as the most troublesome disease feature resulting from the increasing...

    Margherita Fabbri, Raquel Barbosa, Olivier Rascol in Neurology and Therapy
    Article Open access 12 January 2023
Did you find what you were looking for? Share feedback.